QuiaPEG Pharmaceuticals Holding AB

FRA:99B0 (Sweden)  
€ 0.00 (0%) Nov 29
At Loss
P/B:
1.49
Market Cap:
€ 2.69M ($ 2.84M)
Enterprise V:
€ 2.46M ($ 2.60M)
Volume:
-
Avg Vol (2M):
-
Trade In:

Business Description

Description
QuiaPEG Pharmaceuticals Holding AB is a biotech company. It develops biopharmaceuticals based PEGylation technologies platform, which is applicable to proteins, peptides, and small molecules or oligonucleotides.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.13
Equity-to-Asset 0.82
Debt-to-Equity 0.59
Debt-to-EBITDA -2.13
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 26.84
9-Day RSI 36.32
14-Day RSI 41.5
6-1 Month Momentum % -57.69
12-1 Month Momentum % -29.03

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.55
Quick Ratio 0.55
Cash Ratio 0.33
Days Sales Outstanding 34.18

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -305.2
Shareholder Yield % -56.11

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % 156.44
Operating Margin % -575
Net Margin % -587.29
FCF Margin % -1259.33
ROE % -70.92
ROA % -38.12
ROIC % -31.46
ROC (Joel Greenblatt) % -4334.82
ROCE % -57.89
Years of Profitability over Past 10-Year 2

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 5.7
PB Ratio 1.49
EV-to-EBIT -2.1
EV-to-EBITDA -2.97
EV-to-Revenue 12.09
EV-to-FCF -1.64
Earnings Yield (Greenblatt) % -47.52
FCF Yield % -94.81

Financials (Next Earnings Date:2025-02-26)

FRA:99B0's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

QuiaPEG Pharmaceuticals Holding AB Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 0.209
EPS (TTM) (€) -0.003
Beta 4.52
Volatility % 162.37
14-Day RSI 41.5
14-Day ATR (€) 0.000384
20-Day SMA (€) 0.002195
12-1 Month Momentum % -29.03
52-Week Range (€) 0.0001 - 0.0153
Shares Outstanding (Mil) 1,489.98

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

QuiaPEG Pharmaceuticals Holding AB Filings

Filing Date Document Date Form
No Filing Data

QuiaPEG Pharmaceuticals Holding AB Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

QuiaPEG Pharmaceuticals Holding AB Frequently Asked Questions

What is QuiaPEG Pharmaceuticals Holding AB(FRA:99B0)'s stock price today?
The current price of FRA:99B0 is €0.00. The 52 week high of FRA:99B0 is €0.02 and 52 week low is €0.00.
When is next earnings date of QuiaPEG Pharmaceuticals Holding AB(FRA:99B0)?
The next earnings date of QuiaPEG Pharmaceuticals Holding AB(FRA:99B0) is 2025-02-26.
Does QuiaPEG Pharmaceuticals Holding AB(FRA:99B0) pay dividends? If so, how much?
QuiaPEG Pharmaceuticals Holding AB(FRA:99B0) does not pay dividend.

Press Release

Subject Date
No Press Release